Covid-19后新诊断糖尿病的发病率
该研究基于德国1171家诊所的回顾性队列数据,将35,865例Covid-19患者与倾向评分匹配的急性上呼吸道感染对照进行比较,发现Covid-19组2型糖尿病发病率升高(15.8 vs 12.3/1000人年),IRR为1.28(95%CI 1.05,1.57),其他类型糖尿病IRR未升高。
要点
- Covid-19患者2型糖尿病发病率为15.8/1000人年,高于上呼吸道感染对照组的12.3/1000人年。
- 匹配后2型糖尿病IRR为1.28(95%CI 1.05,1.57),其他类型糖尿病IRR未升高。
- 作者认为若结果被证实,支持轻症SARS-CoV-2感染康复后主动监测血糖异常。
核心结论
- Covid-19增加2型糖尿病风险;若被证实,这些结果支持对轻症SARS-CoV-2感染康复后主动监测血糖异常。
研究设计与样本
- 新诊断糖尿病依据ICD-10编码定义(2型糖尿病E11;其他类型糖尿病E12-E14),随访至2021年7月(Covid-19中位随访119天,急性上呼吸道感染中位随访161天)。
- 按性别、年龄、医保类型、Covid-19/急性上呼吸道感染索引月份及合并症(肥胖、高血压、高脂血症、心肌梗死、卒中)进行1:1倾向评分匹配。
- 排除索引日期后30天内使用皮质类固醇者;采用泊松回归模型估计糖尿病发病率比(IRR)。
- 研究期间有35,865例记录在案的Covid-19患者;匹配后35,865例急性上呼吸道感染对照的人口学和临床特征相似(平均年龄43岁;女性46%)。
主要发现
- Covid-19组2型糖尿病发病率为15.8/1000人年,急性上呼吸道感染对照组为12.3/1000人年。
- 采用边际模型考虑匹配对内观察相关性后,2型糖尿病IRR为1.28(95%CI 1.05,1.57)。
- 其他类型糖尿病的IRR未升高。
临床怎么用
- 作者认为若结果被证实,支持对轻症SARS-CoV-2感染康复后主动监测血糖异常。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this work was to investigate diabetes incidence after infection with coronavirus disease-2019 (Covid-19). Individuals with acute upper respiratory tract infections (AURI), which are frequently caused by viruses, were selected as a non-exposed control group. METHODS: We performed a retrospective cohort analysis of the Disease Analyzer, which comprises a representative panel of 1171 physicians' practices throughout Germany (March 2020 to January 2021: 8.8 million patients). Newly diagnosed diabetes was defined based on ICD-10 codes (type 2 diabetes: E11; other forms of diabetes: E12-E14) during follow-up until July 2021 (median for Covid-19, 119 days; median for AURI 161 days). Propensity score matching (1:1) for sex, age, health insurance, index month for Covid-19/AURI and comorbidity (obesity, hypertension, hyperlipidaemia, myocardial infarction, stroke) was performed. Individuals using corticosteroids within 30 days after the index dates were excluded. Poisson regression models were fitted to obtain incidence rate ratios (IRRs) for diabetes. RESULTS: There were 35,865 individuals with documented Covid-19 in the study period. After propensity score matching, demographic and clinical characteristics were similar in 35,865 AURI controls (mean age 43 years; 46% female). Individuals with Covid-19 showed an increased type 2 diabetes incidence compared with AURI (15.8 vs 12.3 per 1000 person-years). Using marginal models to account for correlation of observations within matched pairs, an IRR for type 2 diabetes of 1.28 (95% CI 1.05, 1.57) was estimated. The IRR was not increased for other forms of diabetes. CONCLUSIONS/INTERPRETATION: Covid-19 confers an increased risk for type 2 diabetes. If confirmed, these results support the active monitoring of glucose dysregulation after recovery from mild forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
引用
- Rathmann W, Kuss O, Kostev K, et al. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022. PMID: 35292829. doi:10.1007/s00125-022-05670-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。